Monday, October 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 5, 2026

Wells Fargo Stock Jumps Nearly 19% in 3 Months: Right Time to Buy?

View original at finance.yahoo.com
Wells Fargo Stock Jumps Nearly 19% in 3 Months: Right Time to Buy? Shares of Wells Fargo & Company WFC have gained 18.6% in the past three months compared with the industry’s rise of 9.1%…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Zacks Consensus Estimate for WFC 2026 sales suggests 5.4% growth

    80% confidence

  • Zacks Consensus Estimate for WFC 2026 earnings indicates 11.7% rally

    80% confidence

  • Wells Fargo raised medium-term ROTCE target to 17-18% from earlier 15%

    80% confidence

  • Wells Fargo carries Zacks Rank #2 (Buy)

    80% confidence

  • Wells Fargo stock worth investing in now for solid long-term returns

    80% confidence

  • Management characterized AI transition as a 'positive reality' suggesting AI-enabled efficiencies will support long-term operational improvements

    80% confidence

  • Zacks Consensus Estimate for WFC 2025 sales suggests 2.1% growth

    80% confidence

  • Wells Fargo plans to introduce AI gradually over next year and continue expanding use beyond 2026

    80% confidence

  • Wells Fargo signaled workforce could shrink in 2026 as part of push to improve efficiency and incorporate AI

    80% confidence

  • Wells Fargo expects to achieve $15 billion in gross expense savings by end of 2025

    80% confidence

  • Zacks Consensus Estimate for WFC 2025 earnings indicates 16.9% rally

    80% confidence

  • Wells Fargo expects 2025 NII to be in line with 2024 NII of $47.7 billion

    80% confidence

  • By end of 2025, slightly more than half of branch network expected to be refreshed

    80% confidence

  • Wells Fargo targets up to $10 billion in annual cost cuts

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Wells Fargo Stock Jumps Nearly 19% in 3 Months: Right Time to Buy? — Source | Via News | ViaNews Market